Enzyme-mediated methodology for the site-specific radiolabeling of antibodies based on catalyst-free click chemistry

Bioconjugate Chemistry

Volumn 24, Issue 6, 2013, Pages 1057-1067

  Zeglis, Brian M ^a   Davis, Charles B ^a   Aggeler, Robert ^b   Kang, Hee Chol ^b   Chen, Aimei ^b   Agnew, Brian J ^b   Lewis, Jason S ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b MOLECULAR PROBES INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHAINS; CHELATION; ENZYMES; POLYSACCHARIDES; SUGARS; SYNTHESIS (CHEMICAL); TUMORS;

CATALYST-FREE; CLICK CHEMISTRY; DESFERRIOXAMINE; ENZYME CHEMISTRY; ENZYME-MEDIATED; GLYCANS; HEAVY CHAIN; RADIOLABELLING; SITE SELECTIVE; SITE-SPECIFIC;

ANTIBODIES;

AZIDE; DEFEROXAMINE; GLYCAN; MONOCLONAL ANTIBODY J591; N ACETYLGALACTOSAMINE; N ACETYLGLUCOSAMINE; ZIRCONIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLICK CHEMISTRY; HEAVY CHAIN; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; IN VITRO STUDY; ISOTOPE LABELING; MALE; MOUSE; NONHUMAN; XENOGRAFT;

MUS MUSCULUS;

EID: 84879364396     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc400122c     Document Type: Article

References (59)

1. Wu, A. M. (2009) Antibodies and antimatter: The resurgence of immuno-PET J. Nucl. Med. 50, 2-5
2. Zalutsky, M. R. and Lewis, J. S. (2003) Radiolabeled antibodies for tumor imaging and therapy Handb. Radiopharm. 685-714
3. Zeglis, B. M. and Lewis, J. S. (2011) A practical guide to the construction of radiometallated bioconjugates for positron emission tomography Dalton Trans. 40, 6168-6195
4. Cheng, Z., De Jesus, O. P., Namavari, M., De, A., Levi, J., Webster, J. M., Zhang, R., Lee, B., Syud, F. A., and Gambhir, S. S. (2008) Small-animal PET imaging of human epidermal growth factor receptor type 2 expression with site-specific 18F-labeled protein scaffold molecules J. Nucl. Med. 49, 804-813
5. Gill, H. S., Tinianow, J. N., Ogasawara, A., Flores, J. E., Vanderbilt, A. N., Raab, H., Scheer, J. M., Vandlen, R., Williams, S. P., and Mark, J. (2009) A modular platform for the rapid site-specific radioalbeling of proteins with 18F exemplified by quantitative positron emission tomography of human epidermal growth factor receptor 2 J. Med. Chem. 52, 5816-5825
6. Hussain, A. F., Kampmeier, F., von Felbert, V., Merk, H. F., Tur, M. K., and Barth, S. (2011) SNAP-Tag technology mediates site-specific conjugation of antibody fragments with a photosensitizer and improves target specific phototoxicity in tumor cells Bioconjugate Chem. 22, 2487-2495
7. Jeong, J. M., Lee, J., Paik, C. H., Kim, D. K., Lee, D. S., Chung, J. K., and Lee, M. C. (2004) Site-specific 99mTc-labeling of antibody using dihydraziniophthalazine (DHZ) conjugation to Fc region of heavy chain Arch. Pharm. Res. 27, 961-967
8. Kampmeier, F., Ribbert, M., Nachreiner, T., Dembski, S., Beaufils, F., Brecht, A., and Barth, S. (2009) Site-specific, covalent labeling of recombinant antibody fragments via fusion to an engineered version of 6-O-alkylguanine DNA alkyltransferase Bioconjugate Chem. 20, 1010-1015
9. Li, L., Crow, D., Turatti, F., Bading, J. R., Anderson, A. L., Poku, E., Yazaki, P., Carmichael, J., Leong, D., Wheatcroft, M. P., Raubitschek, A. A., Hudson, P. J., Colcher, D., and Shivley, J. E. (2011) Site-specific conjugation of monodispersed DOTA-PEGn to a thiolated diabody reveals the effect of incrasing PEG size on kidney clearance and tumor uptake with improved 64-copper PET imaging Bioconjugate Chem. 22, 709-716
10. Tinianow, J. N., Gill, H. S., Ogasawara, A., Flores, J. E., Vanderbilt, A. N., Luis, E., Vandlen, R., Darwish, M., Junutula, J. R., Williams, S. P., and Marik, J. (2010) Site-specifically Zr-89-labeled monoclonal antibodies for ImmunoPET Nucl. Med. Biol. 37, 289-297
11. Raju, T. S., Briggs, J. B., Borge, S. M., and Jones, A. J. (2000) Species-specific variation in glycosylation of IgG: evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics Glycobiology 10, 477-486
12. Wolfe, C. A. and Hage, D. S. (1995) Studies on the rate and control of antibody oxidation by periodate Anal. Biochem. 231, 123-130
13. Clamp, J. R. and Hough, L. (1966) Some observations on the periodate oxidation of amino compounds Biochem. J. 101, 120-126
14. Ramakrishnan, B. and Qasba, P. K. (2002) Structure-based design of beta 1,4-galactosyltransferase I (beta 4Gal-T1) with equally efficient N-acetylgalactosaminyltransferase activity: point mutation broadens beta 4Gal-T1 donor specificity J. Biol. Chem. 7, 20833-20839
15. Clark, P. M., Dweck, J. F., Mason, D. E., Hart, C. R., Buck, S. B., Peters, E. C., Agnew, B. J., and Hsieh-Wilson, L. C. (2008) Direct in-gel fluorescence detection and cellular imaging of O-GlcNAc-modified proteins J. Am. Chem. Soc. 130, 11576-11577
16. Boeggeman, E., Ramakrishnan, B., Kilgore, C., Khidekel, N., Hsieh-Wilson, L. C., Simpson, J. T., and Qasba, P. K. (2007) Direct identification of nonreducing GlcNAc residues on N-Glycans of glycoproteins using a novel chemoenzymatic method Bioconjugate Chem. 18, 806-814
17. Boeggeman, E., Ramakrishnan, B., Pasek, M., Manzoni, M., Puri, A., Loomis, K. H., Waybright, T. J., and Qasba, P. K. (2009) Site specific conjugation of fluoroprobes to the remodeled Fc N-Glycans of monoclonal antibodies using mutant glycosyltransferases: Application for cell surface antigen detection Bioconjugate Chem. 20, 1228-1236
18. Khidekel, N., Arndt, S., Lamarre-Vincent, N., Lippert, A., Poulin-Kerstien, K. G., Ramakrishnan, B., Qasba, P. K., and Hsieh-Wilson, L. C. (2003) A chemoenzymatic approach toward the rapid and sensitive detection of O-GlcNAc posttranslational modifications J. Am. Chem. Soc. 125, 16162-16163
19. Ramakrishnan, B., Boeggeman, E., Manzoni, M., Zhu, Z., Loomis, K., Puri, A., Dimitrov, D. S., and Qasba, P. K. (2009) Multiple site-specific in vitro labeling of a single-chain antibody Bioconjugate Chem. 20, 1383-1389
20. Agard, N. J. and Bertozzi, C. R. (2009) Chemical approaches to perturb, profile, and perceive glycans Acc. Chem. Res. 42, 788-797
21. Khidekel, N., Ficarro, S. B., Clark, P. M., Bryan, M. C., Swaney, D. L., Rexach, J. E., Sun, Y. E., Coon, J. J., Peters, E. C., and Hsieh-Wilson, L. C. (2007) Probing the dynamics of O-GlcNAc glycosylation in the brain using quantitative proteomics Nat. Chem. Biol. 3, 339-348
22. Tai, H. C., Khidekel, N., Ficarro, S. B., Peters, E. C., and Hsieh-Wilson, L. C. (2004) Parallel identification of O-GlcNAc-modified proteins from cell lysates J. Am. Chem. Soc. 126, 10500-10501
23. Qasba, P. K., Boeggeman, E., and Ramakrishnan, B. (2008) Site-specific linking of biomolecules via glycan residues using glycosyltransferases Biotechnol. Prog. 24, 520-526
24. Ramakrishnan, B., Boeggeman, E., and Qasba, P. K. (2007) Novel method for in vitro O-glycosylation of proteins: Application for bioconjugation Bioconjugate Chem. 18, 1912-1918
25. Ramakrishnan, B., Boeggeman, E., Manzoni, M., Zhu, Z., Loomis, K., Puri, A., Dimitrov, D. S., and Qasba, P. K. (2009) Multiple site-specific in vitro labeling of single-chain antibody Bioconjugate Chem. 20, 1383-1389
26. Vocadlo, D., Hang, H., Kim, E., Hanover, J., and Bertozzi, C. R. (2003) A chemical approach for identifying O-GlcNAc-modified proteins in cells Proc. Nat. Acad. Sci. U. S. A. 100, 9116-9121
27. Kolb, H. C., Finn, M. G., and Sharpless, K. B. (2001) Click chemistry: diverse chemical function from a few good reactions Angew. Chem., Int. Ed. 40, 2004-2021
28. Wadas, T. J., Wong, E. H., Weisman, G. R., and Anderson, C. J. (2010) Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease Chem. Rev. 110, 2858-2902
29. Sletten, E. M. and Bertozzi, C. R. (2009) Bioorthogonal chemistry: fishing for selectivity in a sea of functionality Angew. Chem., Int. Ed. 48, 6973-6998
30. Ning, X., Guo, J., Wolfert, M. A., and Boons, G. J. (2008) Visualizing metabolically labeled glycoconjugates of living cells by copper-free and fast huisgen cycloadditions Angew. Chem., Int. Ed. 47, 2253-2255
31. Laughlin, S. T., Baskin, J. M., Amacher, S. L., and Bertozzi, C. R. (2008) In vivo imaging of membrane-associated glycans in developing zebrafish Science 320, 664-667
32. Laughlin, S. T. and Bertozzi, C. R. (2007) Metabolic labeling of glycans with azido sugars and subsequent glycan-profiling and visualization via Staudinger ligation Nat. Protoc. 2, 2930-2944
33. Zaro, B. W., Yang, Y. Y., Hang, H. C., and Pratt, M. R. (2011) Chemical reporters for fluorescent detection and identification of O-GlcNAc-modified proteins reveal glycosylation of the ubiquitin ligase NEDD4-1 Proc. Nat. Acad. Sci. U. S. A. 108, 8146-8151
34. Boeggeman, E., Ramakrishnan, B., and Qasba, P. K. (2003) The N-terminal stem region of bovine and human beta1,4-galactosyltransferase I increases the in vitro folding efficiency of their catalytic domain from inclusion bodies Protein Express. Purif. 30, 219-229
35. Holland, J. P., Sheh, Y. C., and Lewis, J. S. (2009) Standardized methods for the production of high specific-activity zirconium-89 Nucl. Med. Biol. 36, 729-739
36. Hang, H. C., Yu, C., Kato, D. L., and Bertozzi, C. R. (2003) A metabolic labeling approach toward proteomic analysis of mucin-type O-linked glycosylation Proc. Nat. Acad. Sci. U. S. A. 100, 14846-14851
37. Vosjan, M., Perk, L. R., Visser, G. W. M., Budde, M., Jurek, P., Kiefer, G. E., and van Dongen, G. (2010) Conjugation and radiolabeling of monoclonal antibodies with zirconium-89 for PET imaging using the bifunctional chelate p-isothiocyanatobenzyl-desferrioxamine Nat. Protoc. 5, 739-743
38. Lindmo, T., Boven, E., Cuttitta, F., Fedorko, J., and Bunn, P. A., Jr. (1984) Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess J. Immunol. Methods 72, 77-89
39. Lindmo, T. and Bunn, P. A., Jr. (1986) Determination of the true immunoreactive fraction of monoclonal antibodies after radiolabeling Methods Enzymol. 121, 678-91
40. Anderson, C. J., Connett, J. M., Schwarz, S. W., Rocque, P. A., Guo, L. W., Philpott, G. W., Zinn, K. R., Meares, C. F., and Welch, M. J. (1992) Copper-64-labeled antibodies for PET imaging J. Nucl. Med. 33, 1685-1691
41. Holland, J. P., Caldas-Lopes, E., Divilov, V., Longo, V. A., Taldone, T., Zatorska, D., Chiosis, G., and Lewis, J. S. (2010) Measuring the pharmacodynamic effects of a novel Hsp90 inhibitor on HER2/neu expression in mice using Zr-89-DFO-trastuzumab. Plos One, 5.
42. Holland, J. P., Divilov, V., Bander, N. H., Smith-Jones, P. M., Larson, S. M., and Lewis, J. S. (2010) Zr-89-DFO-J591 for ImmunoPET of prostate-specific membrane antigen expression in vivo J. Nucl. Med. 51, 1293-1300
43. Vugts, D. J. and Van Dongen, G. (2011) 89Zr-labeled compounds for PET imaging guided personalized therapy Drug Disc overy Today 8, e53-e61
44. Liu, H., Moy, P., Kim, S., Xia, Y., Rajasekaran, A., Navarro, V., Knudsen, B., and Bander, N. H. (1997) Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor vascular endothelium Cancer Res. 57, 3629-3634
45. Liu, H., Rajasekaran, A. K., Moy, P., Xia, Y., Kim, S., Navarro, V., Rahmati, R., and Bander, N. H. (1998) Constitutive and antibody-induced internalization of prostate-specific membrane antigen Cancer Res. 58, 4055-4060
46. Olson, W. C., Heston, W. D. W., and Rajasekaran, A. K. (2007) Clinical trials of cancer therapies targeting prostate-specific membrane antigen Rev. Recent Clin. Trials 2, 182-90
47. Manyak, M. J. (2008) Indium-111 capromab pendetide in the management of recurrent prostate cancer Exp. Rev. Anticancer Ther. 8, 175-181
48. Apolo, A. B., Pandit-Taskar, N., and Morris, M. J. (2008) Novel tracers and their development for the imaging of metastatic prostate cancer J. Nucl. Med. 49, 2031-2041
49. Cho, S. Y., Gage, K. L., Mease, R. C., Senthamizhchelvan, S., Holt, D. P., Jeffrey-Kwanisai, A., Endres, C. J., Dannals, R. F., Sgouros, G., Lodge, M., Eisenberger, M. A., Rodriguez, R., Carducci, M. A., Rojas, C., Slusher, B. S., Kozikowski, A. P., and Pomper, M. G. Biodistribution, tumor detection, and radiation dosimetry of F-18-DCFBC, a low-molecular-weight inhibitor of prostate-specific membrane antigen, in patients with metastatic prostate cancer. J. Nucl. Med. 53, 1883-1891.
50. McDevitt, M. R., Barendswaard, E., Ma, D., Lai, L., Curcio, M. J., Sgouros, G., Ballangrud, A. M., Yang, W. H., Finn, R. D., Pellegrini, V., Geerlings, M. W., Lee, M., Brechbiel, M. W., Bander, N. H., Cordon-Cardo, C., and Scheinberg, D. A. (2000) An alpha-particle emitting antibody ([Bi-213]J591) for radioimmunotherapy of prostate cancer Cancer Res. 60, 6095-6100
51. Vallabhajosula, S., Smith-Jones, P. M., Navarro, V., Goldsmith, S. J., and Bander, N. H. (2004) Radioimmunotherapy of prostate cancer in human xenografts using monoclonal antibodies specific to prostate specific membrane antigen (PSMA): Studies in nude mice Prostate 58, 145-155
52. Vallabhajosula, S., Kuji, I., Hamacher, K. A., Konishi, S., Kostakoglu, L., Kothari, P. A., Milowski, M. I., Nanus, D. M., Bander, N. H., and Goldsmith, S. J. (2005) Pharmacokinetics and biodistribution of In-111-Lu-177-labeled J591 antibody specific for prostate-specific membrane antigen: Prediction of Y-90-J591 radiation dosimetry based on In-111 or Lu-177? J. Nucl. Med. 46, 634-641
53. Vallabhajosula, S., Goldsmith, S. J., Kostakoglu, L., Milowsky, M. I., Nanus, D. M., and Bander, N. H. (2005) Radioimmunotherapy of prostate cancer using Y-90- and Lu-177-labeled J591 monoclonal antibodies: Effect of multiple treatments on myelotoxicity Clin. Cancer Res. 11, 7195S-7200S
54. Pandit-Taskar, N., O'Donoghue, J. A., Morris, M. J., Wills, E. A., Schwartz, L. H., Gonen, M., Scher, H. I., Larson, S. M., and Divgi, C. R. (2008) Antibody mass escalation study in patients with castration-resistant prostate cancer using (111)In-J591: Lesion detectability and dosimetric projections for (90)Y Radioimmunotherapy J. Nucl. Med. 49, 1066-1074
55. McDevitt, M. R., Ma, D. S., Lai, L. T., Simon, J., Borchardt, P., Frank, R. K., Wu, K., Pellegrini, V., Curcio, M. J., Miederer, M., Bander, N. H., and Scheinberg, D. A. (2001) Tumor therapy with targeted atomic nanogenerators Science 294, 1537-1540
56. Deri, M. A., Zeglis, B. M., Francesconi, L. C., and Lewis, J. S. PET imaging with Zr-89: From radiochemistry to the clinic. Nucl. Med. Biol. 40, 3-14.
57. Warnock, D., Bai, X., Autote, K., Gonzales, J., Kinealy, K., Yan, B., Qian, J., Stevenson, T., Zopf, D., and Bayer, R. J. (2005) In vitro galactosylation of human IgG at 1 kg scale using recombinant galactosyltransferase Biotechnol. Bioeng. 92, 831-842
58. Hossler, P., Khattak, S. F., and Li, Z. J. (2009) Optimal and consistent protein glycosylation in mammalian cell culture Glycobiology 19, 936-949
59. Alvarez, V. L., Wen, M. L., Lee, C., Lopes, D., Rodwell, J. D., and McKearn, T. J. (1986) Site-specifically modified 111In labelled antibodies give low liver backgrounds and improved radioimmunoscintigraphy Nucl. Med. Biol. 13, 347-352